Accell Clinical Research has been delighted to intensely participate in major global life science events in 2016; this October meet our Business Development team at ESMO 2016 oncology conference held on October 7-11 in Copenhagen, Denmark.

The annual ESMO congress is the premier scientific platform to present oncology research and the ultimate learning experience for congress attendees. Across disciplines and across cultures, ESMO bridges the gap between researchers, clinicians, and patients and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.

Accell has a strong background in oncology with many completed full service clinical studies and consulting projects since 2007. With offices and home-based staff in 7 countries and the head clinical office in Russia, we provide a good coverage of Eastern European population; in addition we have access to a network of trusted partners across the globe allowing us to tap into countries such as Canada, Australia, Latin America and a number of Western European countries. The majority of our clinical team members have experience in conducting oncology trials, and a solid oncology background.

Participation in ESMO 2016 presents an opportunity to the congress attendees to meet our Business Development team and learn about our best practices, success stories, and case studies with oncology trials in Russia, Eastern Europe. ESMO is a fantastic avenue for Accell to integrate with the industry and stay updated with the latest insights into research and development of global oncology research.

We are welcoming ESMO attendees to schedule a meeting with our Business Development Team (Julia Kondakov, Maria Mezentseva) in advance by contacting us at bd@accellclinical.com.